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The mechanisms by which NLRP3 senses inflammasome-activating stimuli remain poorly defined. In this
issue of Immunity, Mitoma et al. (2013) demonstrate that the RNA helicase DHX33 binds to cytosolic dsRNAs
to trigger NLRP3 inflammasome activation.Pattern recognition receptors, such as the
Toll-like receptors (TLRs), nucleotide-
binding domain and leucine-rich repeat
containing receptors molecules (NLRs),
and RIG-I like receptors (RLRs), sense
infection- or damage-associated signals
and activate responses that promote
microbial clearance and restoration of tis-
sue homeostasis. The TLRs and some
NLRs regulate antimicrobial host defense
programs through transcriptional re-
sponses that involve activation of NF-kB
and MAPK or type I interferon (IFN)
signaling pathways. In contrast, a subset
of NLRs regulates posttranslational
processing and activation of caspase-1.
Caspase-1 is synthesized as a proenzyme
that is activated following recruitment
to multiprotein complexes known as in-
flammasomes. Active caspase-1 cleaves
itself and its substrates, the best studied
of which are the interleukin-1 (IL-1) family
cytokines IL-1b and IL-18. Caspase-1
activation results in the secretion of cas-
pase-1-dependent substrates through
poorly defined mechanisms and a pro-
inflammatory form of programmed cell
death termed pyroptosis.
NLR Pyrin-domain containing 3
(NLRP3) induces inflammasome activa-
tion in response to a wide variety of both
microbial and endogenous stress signals.
NLRP3 inflammasome activation requires
two signals, a ‘‘priming’’ signal and an
‘‘activation’’ signal (Mariathasan and
Monack, 2007). Priming is driven by
TLR-mediated sensing of microbial
structures, such as LPS or peptidoglycan,
and the subsequent transcriptional upre-
gulation of NLRP3 and the pro-form of
IL-1b. Activation is induced by a second
stimulus, such as high concentrations of
extracellular ATP, membrane disruption
via microbial pore-forming toxins or94 Immunity 39, July 25, 2013 ª2013 Elseviecrystals, or the presence of cytosolic
double-stranded RNAs (dsRNAs), which
trigger assembly of an NLRP3-containing
inflammasome complex. Precisely how
these second signals trigger NLRP3
inflammasome activation is not clear;
however, NLRP3 inflammasome activa-
tion contributes to antimicrobial defense,
as well as to the progression of auto-
inflammatory pathological conditions,
and is therefore an active area of
investigation.
NLRs were initially thought to be
sensor proteins that directed caspase-1
activation in response to infection or
stress stimuli via an adaptor protein,
ASC. However, recent studies found that
different NAIP proteins act as upstream
sensors that discriminate between
bacterial flagellin and structurally related
proteins of virulence-associated bacterial
secretion systems to activate the NLRC4
inflammasome (Kofoed and Vance,
2011). These findings suggested that at
least some NLRs function as coadaptors
with ASC and that the sensors of inflam-
masome-activating stimuli are distinct
from the NLRs themselves. Intriguingly,
in this issue of Immunity, Mitoma et al.
now report that the DExD/H-box helicase,
DHX33, is an upstream sensor that
binds to cytosolic dsRNA and induces
NLRP3-dependent inflammasome acti-
vation (Figure 1).
DHX33 is a nucleolar RNA helicase that
was recently found to play a role in 47S
ribosomal RNA (rRNA) biogenesis (Zhang
et al., 2011). By using a coexpression
approach, Mitoma et al. first identified
DHX33 as one of several RNA helicases
that interacts with NLRP3, and further
found that small hairpin RNA (shRNA)-
mediated targeting of DHX33 prevented
poly I:C- or reovirus RNA-induced cas-r Inc.pase-1 processing and IL-1b and IL-18
secretion by THP-1 monocytic cells, but
not in response to nigericin or LPS+ATP
treatment, two other NLRP3 inflamma-
some triggers.
Mitoma et al. next demonstrated that
biotinylated poly I:C, biotinylated reoviral
RNA, and biotinylated E. coli RNA bound
to purified DHX33, and that this binding
was competed by unlabeled poly I:C,
suggesting that DHX33 might act as a
direct sensor of dsRNA. The authors
utilize this system to dissect the mole-
cular requirements of the DHX33-dsRNA
interaction and observed that the helicase
C (helic C) domain, a conserved domain
found in RNA helicase superfamily
proteins, is responsible for binding of
dsRNA to DHX33 (Figure 1). The authors
elegantly demonstrated that expres-
sion of an shRNA-insensitive wild-type
DHX33, but not a helicase C-deletion
mutant, restored the ability of DHX33
shRNA-targeted cells to secrete IL-18
and IL-1b and to activate caspase-1 in
THP1 cells stimulated with dsRNA.
Moreover, the ability of DHX33 to sense
cytosolic dsRNA was independent of
its function in rRNA biogenesis, indi-
cating that the DHX33 participates
in multiple aspects of RNA metabolism
in different cellular compartments. Finally,
stimulation of primary human monocyte-
derived macrophages with reoviral RNA
induced formation of a DHX33-NLRP3-
ASC-containing complex.
This study identifies a player in NLRP3
inflammasome activation and raises a
number of intriguing questions related
to the mechanisms and consequences
of nucleic acid detection by innate
immune pattern recognition receptors.
The RLRs RIG-I and MDA5 are also
DExD/H-box family RNA helicases and
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Figure 1. DHX33 Regulates NLRP3 Inflammasome Activation by dsRNA
Binding of dsRNA to the DHX33 helic C domain leads to DHX33-DEAD-Box and NLRP3-NACHT domain
interactions and assembly of a DHX33-NLRP3-ASC-caspase-1 complex that mediates processing and
secretion of IL-1b and IL-18. How binding of dsRNA by DHX33 (1) results in DHX33-NLRP3 interaction,
andwhether NLRP3may also participate in the interaction between dsRNA and the DHX33 helic C domain
(2), remains to be determined. Abbreviations are as follows: LRR, leucine rich repeat; NBD, nucleotide
binding domain; PYD, pyrin domain; CARD, caspase activation and recruitment domain; DUF, domain
of unknown function, helicase C-terminal domain; HA2, helicase associated domain 2.
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response to cytosolic dsRNA and RNA vi-
rus infection (Nakhaei et al., 2009). How-
ever, the RLRs sense dsRNAs through
the DExD/H-Box helicase domain, in
contrast to DHX33, which utilizes the helic
C domain. Intriguingly, RIG-I can also
interact with ASC to induce inflamma-
some activation in response to RNA virus
infection, but this pathway does not
involve interactions with NLRP3 (Poeck
et al., 2010). The mechanisms that deter-
mine which pattern recognition sensors
and response pathways are engaged by
different stimuli are therefore still not
clear, and may depend on the precise na-
ture of the microbial infection and the
cellular context of the stimulus or ligand.
Mitoma et al. also found that shRNA tar-
geting of DHX33 substantially reducedcaspase-1 activation and caspase-1-
dependent cytokine secretion in response
to bacterial RNA, suggesting that DHX33
functions as a general sensor that
couples detection of cytosolic dsRNA
to NLRP3 inflammasome activation.
Cytosolic bacterial RNA was previously
found to induce NLRP3 inflammasome
activation (Kanneganti et al., 2006;
Sander et al., 2011) and was recently
proposed to activate a noncanonical in-
flammasome, which utilizes caspase-11,
rather than caspase-1 (Rathinam et al.,
2012). The upstream sensing mecha-
nisms involved in noncanonical inflam-
masome activation are unclear (Broz
and Monack, 2013), but the findings of
Mitoma and colleagues raise the question
of whether DHX33 participates in non-
canonical inflammasome activation andImmunwhether caspase-11 is also involved in
the response to viral dsRNA. How
DHX33 distinguishes between exogenous
dsRNAs and endogenous RNAs that
contain regions of double-stranded sec-
ondary structure also remains to be
investigated. Discrimination between self
and nonself nucleic acids could occur
via detection of either virus or bacteria-
specific modifications that are lacking
in cellular RNAs or, conversely, the
presence of cellular modifications, such
as polyadenylation, that are absent from
microbial RNAs (Sander et al., 2011).
The underlying basis of how DHX33
mediates NLRP3 inflammasome assem-
bly upon recognition of dsRNA also
remains to be determined. Mitoma et al.
found that the DEAD domain of DHX33
and the central NACHT domain of
NLRP3 were required for DHX33-NLRP3
interaction. Binding of dsRNA by DHX33
may result in a conformational change
that exposes the DHX33 DEAD domain
for interaction with NLRP3 binding, or
dsRNA may simultaneously interact with
both DHX33 and NLRP3 (Figure 1). Future
structural studies may provide insight into
the molecular interactions between the
key players of the DHX33-NLRP3 inflam-
masome. Given that DHX33 can respond
to the cytosolic presence of both viral
and bacterial RNA species, it will be of
interest to determine whether DHX33
plays a role in host defense against partic-
ular classes of viral or bacterial infections
and whether a particular structural motif
common to both dsRNA viruses and
bacterial RNA species is detected by the
helicase C domain of DHX33 or additional
proteins enable further discrimination
between dsRNA structures from diverse
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